A Study of LY2880070 in Participants With Advanced or Metastatic Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 84
Summary
- Conditions
- Endometrial Cancer
- Breast Cancer
- Colon Cancer
- Colorectal Cancer
- Neoplasms
- Ovarian Cancer
- Pancreas Cancer
- Pancreatic Cancer
- Triple -Negative Breast Cancer
- Rectal Cancer
- Soft Tissue Sarcoma
- Solid Tumors
- Type
- Interventional
- Phase
- Phase 1Phase 2
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Basic Science
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02632448
- Collaborators
- Not Provided
- Investigators
- Study Director: Email: choruspharma@lists.lilly.com Esperas Pharma Inc.
Get Well Soon